The PI3K-AKT-mTOR pathway hyperactivation leads to increased intracellular glucose uptake and reduced hepatic gluconeogenesis, with net hypoglycaemia in the absence of serum insulin. This evidence concerns the gene AKT1 and Hypoglycemia.